Simplifying the management of heart failure across the range of ejection fraction
Seminar
•
AstraZeneca
About the CPD course
A thorough presentation developed for UK based cardiologists and cardiology-specialist nurses; highlighting the evolving landscape in heart failure; and the burden of HFrEF (heart failure with reduced ejection fraction) and HFpEF (heart failure with preserved ejection fraction) on those suffering from these.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
